MeSH term | MeSH ID | Detail |
---|---|---|
Airway Obstruction | D000402 | 13 associated lipids |
Virodhamine is a lipid of Fatty Acyls (FA) class. Virodhamine is associated with abnormalities such as abnormal fragmented structure. The involved functions are known as Ionization, Diastasis, GTP Binding, Mass-to-Charge Ratio and esterase activity. Virodhamine often locates in Body tissue, Plasma membrane and Skin. The related lipids are Arachidonic Acid, AM 404, methanandamide and Fatty Acids.
To understand associated biological information of virodhamine, we collected biological information of abnormalities, associated pathways, cellular/molecular locations, biological functions, related genes/proteins, lipids and common seen animal/experimental models with organized paragraphs from literatures.
virodhamine is suspected in and other diseases in descending order of the highest number of associated sentences.
Disease | Cross reference | Weighted score | Related literature |
---|
We collected disease MeSH terms mapped to the references associated with virodhamine
MeSH term | MeSH ID | Detail |
---|---|---|
Airway Obstruction | D000402 | 13 associated lipids |
There are no associated biomedical information in the current reference collection.
Associated locations are in red color. Not associated locations are in black.
Location | Cross reference | Weighted score | Related literatures |
---|
Function | Cross reference | Weighted score | Related literatures |
---|
Lipid concept | Cross reference | Weighted score | Related literatures |
---|
There are no associated biomedical information in the current reference collection.
There are no associated biomedical information in the current reference collection.
Authors | Title | Published | Journal | PubMed Link |
---|---|---|---|---|
pmid: | ||||
Porter AC et al. | Characterization of a novel endocannabinoid, virodhamine, with antagonist activity at the CB1 receptor. | 2002 | J. Pharmacol. Exp. Ther. | pmid:12023533 |
Ho WS and Hiley CR | Vasorelaxant activities of the putative endocannabinoid virodhamine in rat isolated small mesenteric artery. | 2004 | J. Pharm. Pharmacol. | pmid:15233865 |
Lambert DM and Fowler CJ | The endocannabinoid system: drug targets, lead compounds, and potential therapeutic applications. | 2005 | J. Med. Chem. | pmid:16078824 |
Hayase T et al. | Persistent anxiogenic effects of a single or repeated doses of cocaine and methamphetamine: interactions with endogenous cannabinoid receptor ligands. | 2005 | Behav Pharmacol | pmid:16148444 |
Richardson D et al. | Quantitative profiling of endocannabinoids and related compounds in rat brain using liquid chromatography-tandem electrospray ionization mass spectrometry. | 2007 | Anal. Biochem. | pmid:17141174 |
Gkoumassi E et al. | Virodhamine and CP55,940 modulate cAMP production and IL-8 release in human bronchial epithelial cells. | 2007 | Br. J. Pharmacol. | pmid:17558435 |
Pertwee RG | GPR55: a new member of the cannabinoid receptor clan? | 2007 | Br. J. Pharmacol. | pmid:17876300 |
Ryberg E et al. | The orphan receptor GPR55 is a novel cannabinoid receptor. | 2007 | Br. J. Pharmacol. | pmid:17876302 |
Sun Y et al. | Cannabinoid activation of PPAR alpha; a novel neuroprotective mechanism. | 2007 | Br. J. Pharmacol. | pmid:17906680 |